Hui‐Ling Ko

Apolipoprotein C1 (<scp>APOC</scp>1) as a novel diagnostic and prognostic biomarker for lung cancer: A marker phase <scp>I</scp> trial

Hui‐Ling Ko, Yu‐Shan Wang, Weng‐Lam Fong et al. · Thoracic Cancer · 2014 · 73 citations · Full text

Angiogenic Blockade and Radiotherapy in Hepatocellular Carcinoma

Kwan‐Hwa Chi, Chao‐Sheng Liao, Chih‐Chia Chang et al. · International Journal of Radiation Oncology*Biology*Physics · 2010 · 51 citations

Hepatology, Angiogenic Blockade, Medicine +6

Addition of rapamycin and hydroxychloroquine to metronomic chemotherapy as a second line treatment results in high salvage rates for refractory metastatic solid tumors: a pilot safety and effectiveness analysis in a small patient cohort

Kwan‐Hwa Chi, Hui‐Ling Ko, Kailin Yang et al. · Oncotarget · 2015 · 37 citations · Full text

Axitinib in combination with radiotherapy for advanced hepatocellular carcinoma: a phase I clinical trial

Kailin Yang, Mau‐Shin Chi, Hui‐Ling Ko et al. · Radiation Oncology · 2021 · 25 citations · Full text

Trimodality bladder-sparing approach without neoadjuvant chemotherapy for node-negative localized muscle-invasive urinary bladder cancer resulted in comparable cystectomy-free survival

Cheng‐Yen Lee, Kailin Yang, Hui‐Ling Ko et al. · Radiation Oncology · 2014 · 22 citations · Full text